化合物ENMD-2076 T2358
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
2 mg | 934353-76-1 | ¥468.00 | 询底价 |
10 mg | 934353-76-1 | ¥1,160.00 | 询底价 |
5 mg | 934353-76-1 | ¥689.00 | 询底价 |
50 mg | 934353-76-1 | ¥3,290.00 | 询底价 |
25 mg | 934353-76-1 | ¥2,080.00 | 询底价 |
1 mg | 934353-76-1 | ¥347.00 | 询底价 |
1 mL | 934353-76-1 | ¥773.00 | 询底价 |
Product Introduction
Bioactivity
英文名: ENMD-2076
描述: ENMD2076是一种多靶点激酶抑制剂,抑制Aurora A、Flt3、KDR/VEGFR2、Flt4/VEGFR3、FGFR1、FGFR2、Src、PDGFRα的IC50值分别为1.86、14、58.2、15.9、92.7、70.8、20.2 and 56.4 nM。
细胞实验: The antiproliferative effect of ENMD-2076 on adherent tumor cell lines is measured by plating 500 cells per well in a 96-well plate and incubating with ENMD-2076 for 96 hours. Cellular proliferation is measured using the sulforhodamine B assay. The leukemia-derived, nonadherent cell lines are assayed by plating 5 × 103 cells per well in a 96-well plate. The cells are incubated with ENMD-2076 for 48 hours and then survival is assayed using the Alamar Blue reagent. To measure the effect of ENMD-2076 on VEGF- and fibroblast growth factor (FGF)-induced proliferation of human umbilical vein endothelial cell (HUVEC), cells are serum starved for 6 hours, then treated with ENMD-2076 free base, and stimulated with 5 ng/mL bFGF or 25 ng/mL VEGF (R and D Systems) for 72 hours. Cell proliferation is measured using WST-(Only for Reference)
激酶实验: Kinase assays: Recombinant Aurora A and B kinase enzymes and appropriate PanVera Z'-Lyte kinase assay kits are purchased. Assays are carried out in kinase assay buffer (50 mM of HEPES, pH 7.5, 10 mM of MgCl2, 5 mM of EGTA, 0.05% Brij-35) supplemented with 2 mM of DTT. Activities are determined at an ATP concentration equivalent to the apparent Km for each enzyme, and an enzyme concentration that results in approximately 30% phosphorylation of the peptide substrate after 1 hour. Dose–response curves of relative enzyme activity versus ENMD-2076 concentration are plotted with Grafit and used to calculate IC50 values. Potency of ENMD-2076 free base against a select panel of 100 kinase enzymes is determined using the SelectScreen kinase profiling service. ATP concentrations are at the apparent Km for each enzyme or 100 μM if the apparent Km could not be reached. Percent inhibition is determined at an ENMD-2076 free base concentration of 1 μM; for kinases where significant inhibition is noted, IC50 values are determined by generating full 10-point dose–response curves.
体外活性: 在MDA-MB-231异种移植模型中, ENMD-2076可以抑制形成新血管,同时使形成的血管发生退化.在HT29异种移植模型中,ENMD-2076对Flt3以及VEGFR2 / KDR和FGFR1 / 2的激活持续发挥抑制作用.在H929人浆细胞瘤异种移植物中,口服ENMD-2076(50-200 mg / kg /day),其中磷酸 - 组蛋白3(pH3),Ki-67显著降低,裂解的胱天蛋白酶-3显著增加.
体内活性: ENMD-2076作用于PI3K/AKT通路,下调凋亡抑制蛋白。ENMD-2076能够抑制aurora A和B激酶,且诱导细胞周期停在G2/M 期。在多种作用于血管生成的激酶中(IC50=1.86-120 nM),ENMD-2076能够发挥作用,比如VEGFR2/KDR 和VEGFR3, FGFR1和FGFR2, 及PDGFRα。在多种人类实体瘤和血癌细胞系中(IC50=0.025 -0.7 μM),ENMD-2076使细胞停滞在G2/M 期,诱导细胞凋亡
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 97 mg/mL (258.3 mM)
H2O : 1 mg/mL (2.66 mM)
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
关键字: Cluster of differentiation antigen 135 | FLT3 | Aurora Kinase | Inhibitor | Apoptosis | Fibroblast growth factor receptor | CD135 | VEGFR | Platelet-derived growth factor receptor | ENMD 2076 | ENMD2076 | FGFR | ENMD-2076 | Vascular endothelial growth factor receptor | Fms like tyrosine kinase 3 | PDGFR | Src | inhibit
相关产品: Fedratinib | BMS-1 | Talampanel | VU 0364739 hydrochloride | Alvespimycin hydrochloride | Takinib | Neobavaisoflavone | Pemetrexed disodium hemipenta hydrate | (Z)-Guggulsterone | Paederosidic acid
相关库: Drug Repurposing Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Kinase Inhibitor Library | Tyrosine Kinase Inhibitor Library | Anti-Cancer Active Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物ENMD-2076 T2358信息由TargetMol中国为您提供,如您想了解更多关于化合物ENMD-2076 T2358报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途